08.09.2021 22:24:00
|
Azurity Pharmaceuticals, Inc. -- Moody's assigns B2 CFR to Azurity Pharmaceuticals on acquisition of Arbor; outlook stable
Rating Action: Moody's assigns B2 CFR to Azurity Pharmaceuticals on acquisition of Arbor; outlook stableRead the full article at Moody's